Maria Guadalupe Sanchez Parada

Prof. Dr. Maria Guadalupe Sanchez Parada

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 July 2014 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
LFLucia Flores-Contreras
Lucia Flores-Contreras
ASAna Sandoval-Rodriguez
Ana Sandoval-Rodriguez
MMMayra Mena
Mayra Mena
SLSilvia Lucano-Landeros
Silvia Lucano-Landeros
IAInmaculada Arellano-Olivera
Inmaculada Arellano-Olivera
JAJuan Armendariz-Borunda
Juan Armendariz-Borunda
Background The aim of this study was to assess whether two-years treatment with Pirfenidone influences necroinflammation, fibrosis and steatosis, serum levels of TGF-β1, IL-6, TNF-α and CB1 and CB2 gene expression, in patients with chronic hepatitis C (CHC). Methods Twenty-eight patients out of 34 with CHC virus infection were enrolled in the study and received Pirfenidone (1200 mg/day) for 24 months. Six patients dropped out after 12 months of PFD. Liver biopsies and serum samples were obtained at the beginning and end of treatment. Modified HAI was calculated. CB1 and CB2 gene expression was correlated with fibrosis progression alongside with necroinflammation and steatosis. TGF-β1, IL-6, TNF-α and liver transaminases were measured in serum at two-months intervals. HCV genotype and viral load were also assessed. Quality of life was evaluated by SF36 questionnaires and the prognosis of disease was assessed with Child-Pugh score. The Wilcoxon test matched-pair signed ranks were used to analyze the outcomes. Results Intention to treat analyses were performed for biochemistry and clinical parameters. At the end of treatment, necroinflammation grading was reduced in an average of 3.2 points in 82% of patients (p < 0.05) and Ishak’s fibrosis stage decreased 2-points average in 67% of patients (p < 0.05). Steatosis decreased in 61% of patients. IL-6 and TGF-β1 serum levels decreased significantly in 93% and 67% of patients (p < 0.05), respectively, while TNF-α diminished in 47% of patients. ALT and AST tended to normalize in 81% of patients; CB2 mRNA levels increased in 86% and CB1 expression diminished in 29% of patients. Both, quality of life and Child-Pugh score improvements were reported in all patients. Conclusions Pirfenidone for two years benefits CHC patients and improves inflammation, fibrosis and steatosis in higher number of patients as previously shown for 12-months treatment with PFD. Additionally, PFD improved TGFβ1 and IL-6 levels and diminished liver expression of anti-fibrogenic receptor CB2. Trial registration ClinicalTrials.gov identifier: NCT02161952. Protocol Registration Date: 06/11/2014.

26 September 2017 in Environmental Monitoring and Assessment
Verified
Journal Article
Closed access
PDF file
BGB. C. Gómez-Meda
B. C. Gómez-Meda
GZG. M. Zúñiga-González
G. M. Zúñiga-González
LSL. V. Sánchez-Orozco
L. V. Sánchez-Orozco
AZA. L. Zamora-Perez
A. L. Zamora-Perez
JRJ. P. Rojas-Ramírez
J. P. Rojas-Ramírez
MPMaria Guadalupe Sanchez Parada
Maria Guadalupe Sanchez Parada

27 April 2022 in Genes
Verified
Journal Article
Open access
PDF file
PRPaola Mendoza Ramirez
Paola Mendoza Ramirez
MOMildred Alejandra López Olaiz
Mildred Alejandra López Olaiz
Adriana Lizeth Morales FernandezAdriana Lizeth Morales Fernandez
Adriana Lizeth Morales Fernandez
MFMaría Isabel Flores-Echiveste
María Isabel Flores-Echiveste
ANAntonio De Jesus Casillas Navarro
Antonio De Jesus Casillas Navarro
Raúl Cuauhtémoc Baptista RosasRaúl Cuauhtémoc Baptista Rosas
Raúl Cuauhtémoc Baptista Rosas
Type 2 diabetes (T2D) has been linked to the expression of Human Leukocyte Antigens, principally to the Major Histocompatibility Complex Class II, with only scarce reports of Major Histocompatibility Complex Class I in specific populations. The objective of the present work was to explore the presence of polymorphisms in the MHC Class I related to T2D in the Mexican population using the Genome-Wide Association Studies Slim Initiative in Genomic Medicine of the Americas (GWAS SIGMA) database. This database contains information on 3848 Mexican individuals with T2D and 4366 control individuals from the same population without a clinical or hereditary history of the disease. The searching criteria considered a p-value of 1.0. Ten novel, statistically significant nucleotide variants were identified: four polymorphisms associated with HLA-A (A*03:01:01:01) and six with HLA-C (C*01:02:01:01). These alleles have a high prevalence in Latin American populations and could potentially be associated with autoimmunity mechanisms related to the development of T2D complications.

Verified
Journal Article
Open access
PDF file
EGEnrique García Gaona
Enrique García Gaona
AGAlhelí García-Gregorio
Alhelí García-Gregorio
CGCamila García
Camila García
MOMildred Alejandra López Olaiz
Mildred Alejandra López Olaiz
PRPaola Mendoza Ramirez
Paola Mendoza Ramirez
Raúl Cuauhtémoc Baptista RosasRaúl Cuauhtémoc Baptista Rosas
Raúl Cuauhtémoc Baptista Rosas
Type 2 diabetes (T2D) is a chronic systemic disease with a complex etiology, characterized by insulin resistance and mitochondrial dysfunction in various cell tissues. To explore this relationship, we conducted a secondary analysis of complete mtDNA sequences from 1261 T2D patients and 1105 control individuals. Our findings revealed significant associations between certain single-nucleotide polymorphisms (SNPs) and T2D. Notably, the variants m.1438A>G (rs2001030) (controls: 32 [27.6%], T2D: 84 [72.4%]; OR: 2.46; 95%CI: 1.64–3.78; p < 0.001), m.14766C>T (rs193302980) (controls: 498 [36.9%], T2D: 853 [63.1%]; OR: 2.57, 95%CI: 2.18–3.04, p < 0.001), and m.16519T>C (rs3937033) (controls: 363 [43.4%], T2D: 474 [56.6%]; OR: 1.24, 95%CI: 1.05–1.47, p = 0.012) were significantly associated with the likelihood of developing diabetes. The variant m.16189T>C (rs28693675), which has been previously documented in several studies across diverse populations, showed no association with T2D in our analysis (controls: 148 [13.39] T2D: 171 [13.56%]; OR: 1.03; 95%CI: 0.815–1.31; p = 0.83). These results provide evidence suggesting a link between specific mtDNA polymorphisms and T2D, possibly related to association rules, topological patterns, and three-dimensional conformations associated with regions where changes occur, rather than specific point mutations in the sequence.

23 April 2020 in Animals
Verified
Journal Article
Open access
PDF file
ENEduardo Naranjo-Vázquez
Eduardo Naranjo-Vázquez
MPMaria Guadalupe Sanchez Parada
Maria Guadalupe Sanchez Parada
BGBelinda Claudia Gómez-Meda
Belinda Claudia Gómez-Meda
AZAna Lourdes Zamora-Perez
Ana Lourdes Zamora-Perez
Martha GallegosMartha Gallegos
Martha Gallegos
GZGuillermo Zúñiga-González
Guillermo Zúñiga-González
SKH1 hairless mice are widely used in carcinogenesis and dermatology research due to their bare skin, as exposure to different agents is facilitated. Minoxidil is a cosmetic drug that is recognized as a mitogenic agent, and mitogens are suggested to have carcinogenic and mutagenic potential by inducing cell division and increasing the possibility of perpetuating DNA damage. Therefore, we hypothesized that the application of high doses of minoxidil to the skin of hairless mice would increase the number of micronucleated erythrocytes (MNEs) in peripheral blood. The objective of this study was to evaluate the topical administration of high doses of minoxidil on peripheral blood erythrocytes of SKH1 mice by means of micronucleus assay. Minoxidil was administered on the entire body surface of mice every 12 or 24 h. Minoxidil dosing every 24 h increased the number of micronucleated polychromatic erythrocytes (MNPCEs), and dosing every 12 h increased the number of MNEs and MNPCEs, as compared to baseline and the negative control group. No decrease in polychromatic erythrocyte frequencies was observed in the minoxidil groups. Therefore, topical application of high minoxidil doses to mice can produce DNA damage, as observed through an increase in the number of MNEs, without producing cytotoxicity, possibly due to its mitogenic effect.

16 January 2021 in BioMed Research International
Verified
Journal Article
Open access
PDF file
AGAna Elizabeth Gonzalez-Santiago
Ana Elizabeth Gonzalez-Santiago
GZGuillermo Zúñiga-González
Guillermo Zúñiga-González
BGBelinda Claudia Gómez-Meda
Belinda Claudia Gómez-Meda
FCFrancisco Javier Gutiérrez Corral
Francisco Javier Gutiérrez Corral
AZAna Lourdes Zamora-Perez
Ana Lourdes Zamora-Perez
MPMaria Guadalupe Sanchez Parada
Maria Guadalupe Sanchez Parada
Air pollution has become a serious public health problem globally. Recent studies support the harmful effect of air pollution on human health, in addition to scientific evidence that recognizes it as a human carcinogen. The buccal micronucleus cytome (BMC) assay is employed extensively to measure cytotoxic and genotoxic damage in a population exposed to environmental contamination. The objective of this study was to evaluate the cytotoxic and genotoxic effects in healthy young adults exposed to different levels of air pollution and to identify areas with air pollution rates above the regulatory limits. This study was performed through the BMC assay in oral mucosa samples from 80 healthy young adults from the Guadalajara metropolitan zone. Three highly contaminated areas were taken into account: Tlaquepaque, Miravalle, and Las Pintas. Las Aguilas, a less contaminated area, was used as a reference. The frequencies of nuclear abnormalities in the areas with the highest and lowest levels of air pollution were compared with the Mann–Whitney U test. In addition, an analysis of the concentration of environmental pollutants, particulate matter ≤ 10 μm (PM10), ozone (O3), nitrogen dioxide (NO2), sulfur dioxide (SO2), and carbon monoxide (CO), were carried out in the mentioned areas, in order to identify the events above the regulatory limits in a year period. The results showed that young adults exposed to a higher concentration of pollutants showed higher frequencies of nuclear abnormalities. The individuals from the areas of Tlaquepaque, Miravalle, and Las Pintas showed cytotoxic damage since statistically significant differences were found in the abnormalities of pyknotic nuclei (PNs), condensed chromatin (CC), karyorrhexis (KX), and karyolysis (KL). The individuals who showed the most cytotoxic damage were from the Las Pintas area with higher frequencies in nuclear abnormalities (PNs, CC, KX, and KL) (p < 0.0001). Genotoxic damage was found in individuals from two zones, Miravalle and Las Pintas, with statistically significant differences in the abnormality of nuclear buds (NBUDs) (p < 0.0001). Our results suggest that exposure to high levels of air pollution in healthy young adults has an effect on cellular and nuclear integrity and thus in human health, since areas with higher air pollution showed an increase in cytotoxicity, specifically in early and late markers of cell death (CC, KX, PN, and KL) and genotoxic damage (BUDs).